5:44 PM
 | 
Feb 26, 2013
 |  BC Extra  |  Company News

FDA panel to discuss Titan's Probuphine

FDA's Psychopharmacologic Drugs Advisory Committee will meet on March 21 to discuss an NDA for Probuphine buprenorphine...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >